pSivida to trade on German exchanges
Thursday, 15 January, 2004
Perth-based nanotech company pSivida (ASX:PSD) will soon commence trading on the German stock exchanges in Berlin, Munich and Stuttgart after meeting all listing requirements, the company has announced.
According to managing director Gavin Rezos, the listings will raise the investment profile of the company in Europe, particularly as pSivida's UK subsidiary pSiMedica prepares to list in the UK.
The listings won't be accompanied by issue of new shares, but instead will allow European institutional and retail investors to trade pSivida shares more easily.
The company has new ties with Germany following its licensing deal with German research agency Forschungszentrum Julich, which has provided pSivida with optical mirror technology for use in its BioSilicon-based in vivo diagnostics project.
pSivida's share price rose nearly eight per cent to AUD$0.69 yesterday on the news.
New gene therapy treats liver disorder in growing children
Researchers have developed a genome-editing approach that repairs a faulty gene directly at its...
High folic acid in pregnancy could cause early bleeding
Women taking at least 800 micrograms of folic acid daily were more likely to report spotting and...
Genetics shape our personality and life outcomes more than we thought
Scientists have identified >1200 genetic variants associated with personality traits,...
